Laparoscopic Gastric Bypass. Morbid obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients undergoing laparoscopic gastric bypass; ASA Class II -III; morbid obesity (BMI> = 35 kg / m2); Exclusion criteria: With cardiovascular and respiratory diseases, drug and alcohol abuse, renal failure, liver dysfunction and autoimmune disease, diabetes or asthma disease, regular use of steroids and NSAID; core temperature greater than 37 ° C, the number of cells white More than 10 thousand
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 10. Timepoint: Before the induction of anesthesia and end of anesthesia. Method of measurement: In blood plasma sample, by ELISA, according picogeram per mililiter.;TNF Alfa. Timepoint: Before the induction of anesthesia and end of anesthesia. Method of measurement: In blood plasma sample, by ELISA, according picogeram per mililiter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Age. Timepoint: Before entering the study. Method of measurement: Based on the number of years of life on the basis of year.;Height. Timepoint: Before enteiring to study. Method of measurement: Based on the information in the file and on the basis of centimeter.;Wieght. Timepoint: Before entering to study. Method of measurement: Based on the information in the file and on the basis of kilogeram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Razi Vaccine and Serum Research Institute